Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Change in Receivables (2022 - 2025)

Neuraxis' Change in Receivables history spans 4 years, with the latest figure at -$17814.0 for Q3 2025.

  • For Q3 2025, Change in Receivables rose 80.51% year-over-year to -$17814.0; the TTM value through Sep 2025 reached $42348.0, up 212.24%, while the annual FY2024 figure was $178845.0, 335.47% up from the prior year.
  • Change in Receivables for Q3 2025 was -$17814.0 at Neuraxis, up from -$115190.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $185299.0 in Q1 2023 and bottomed at -$169135.0 in Q4 2022.
  • The 4-year median for Change in Receivables is -$17814.0 (2025), against an average of -$6475.5.
  • The largest annual shift saw Change in Receivables surged 537.22% in 2024 before it tumbled 282.95% in 2025.
  • A 4-year view of Change in Receivables shows it stood at -$169135.0 in 2022, then soared by 76.16% to -$40314.0 in 2023, then soared by 537.22% to $176262.0 in 2024, then crashed by 110.11% to -$17814.0 in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Change in Receivables are -$17814.0 (Q3 2025), -$115190.0 (Q2 2025), and -$910.0 (Q1 2025).